199 related articles for article (PubMed ID: 17452424)
21. E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway.
Zhao HB; Wang C; Li RX; Tang CL; Li MQ; Du MR; Hou XF; Li DJ
Biol Reprod; 2010 Sep; 83(3):370-6. PubMed ID: 20427760
[TBL] [Abstract][Full Text] [Related]
22. Adenosine diphosphate-ribosylation factor 6 is required for epidermal growth factor-induced glioblastoma cell proliferation.
Li M; Wang J; Ng SS; Chan CY; He ML; Yu F; Lai L; Shi C; Chen Y; Yew DT; Kung HF; Lin MC
Cancer; 2009 Nov; 115(21):4959-72. PubMed ID: 19642173
[TBL] [Abstract][Full Text] [Related]
23. Tissue plasminogen activator is a potent activator of PDGF-CC.
Fredriksson L; Li H; Fieber C; Li X; Eriksson U
EMBO J; 2004 Oct; 23(19):3793-802. PubMed ID: 15372073
[TBL] [Abstract][Full Text] [Related]
24. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Vickers SM; Buchsbaum DJ; Heslin MJ; Arnoletti JP
J Surg Res; 2007 Nov; 143(1):20-6. PubMed ID: 17950068
[TBL] [Abstract][Full Text] [Related]
25. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
27. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
[TBL] [Abstract][Full Text] [Related]
29. Involvement of connexin43 in the EGF/EGFR signalling during self-renewal and differentiation of neural progenitor cells.
Lemcke H; Kuznetsov SA
Cell Signal; 2013 Dec; 25(12):2676-84. PubMed ID: 24012498
[TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
[TBL] [Abstract][Full Text] [Related]
31. Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells.
Sloss CM; Wang F; Palladino MA; Cusack JC
Oncogene; 2010 May; 29(21):3146-52. PubMed ID: 20208558
[TBL] [Abstract][Full Text] [Related]
32. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor.
Bolitho C; Hahn MA; Baxter RC; Marsh DJ
Endocr Relat Cancer; 2010 Dec; 17(4):929-40. PubMed ID: 20702723
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of a Ras homologue member I on pancreatic cancer and its modulation on epithelium growth factor receptor-Ras-Raf-mitogen-activated protein kinase/extracellular regulated protein kinase/1/2 pathway.
Lu J; Qian JM; Yang H; Li JN; Xu FJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):197-201. PubMed ID: 22776648
[TBL] [Abstract][Full Text] [Related]
34. Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.
Medina MG; Ledesma MD; Domínguez JE; Medina M; Zafra D; Alameda F; Dotti CG; Navarro P
EMBO J; 2005 May; 24(9):1706-16. PubMed ID: 15861134
[TBL] [Abstract][Full Text] [Related]
35. Plasmin is the major protease responsible for processing PDGF-C in the vitreous of patients with proliferative vitreoretinopathy.
Lei H; Velez G; Hovland P; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):42-8. PubMed ID: 18172073
[TBL] [Abstract][Full Text] [Related]
36. Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation.
Zheng Y; Li X; Qian X; Wang Y; Lee JH; Xia Y; Hawke DH; Zhang G; Lyu J; Lu Z
Nat Cell Biol; 2015 Oct; 17(10):1348-55. PubMed ID: 26280537
[TBL] [Abstract][Full Text] [Related]
37. Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function.
Xu D; Makkinje A; Kyriakis JM
J Biol Chem; 2005 Jan; 280(4):2924-33. PubMed ID: 15556944
[TBL] [Abstract][Full Text] [Related]
38. tPA is a potent mitogen for renal interstitial fibroblasts: role of beta1 integrin/focal adhesion kinase signaling.
Hao S; Shen H; Hou Y; Mars WM; Liu Y
Am J Pathol; 2010 Sep; 177(3):1164-75. PubMed ID: 20639453
[TBL] [Abstract][Full Text] [Related]
39. Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway.
Kim SY; Cheon SY; Kim EJ; Lee JH; Kam EH; Kim JM; Park M; Koo BN
Neurochem Res; 2017 May; 42(5):1533-1542. PubMed ID: 28303501
[TBL] [Abstract][Full Text] [Related]
40. Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression.
Hu K; Yang J; Tanaka S; Gonias SL; Mars WM; Liu Y
J Biol Chem; 2006 Jan; 281(4):2120-7. PubMed ID: 16303771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
